Title of article :
Should phosphodiesterase 5 selective inhibitors be used for uterine relaxation?
Author/Authors :
Céline Méhats، نويسنده , , Thomas Schmitz، نويسنده , , Michelle Breuiller-Fouché، نويسنده , , Marie-Josèphe Leroy، نويسنده , , Dominique Cabrol، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2006
Abstract :
Sildenafil citrate is a phosphodiesterase 5-selective inhibitor used successfully in treating erectile dysfunction. High doses of sildenafil can inhibit myometrial contractions. However, no study has demonstrated a role for phosphodiesterase 5 in myometrial contractility. No clinical trial using sildenafil to promote uterine relaxation should be initiated based on the currently available data.
Keywords :
SildenafilPhosphodiesterase5-selective inhibitorMyometriumcontractility
Journal title :
American Journal of Obstetrics and Gynecology
Journal title :
American Journal of Obstetrics and Gynecology